-
Zhejiang Kanglaite Pharmaceutical Co., Ltd., established by Prof. Li Dapeng, is a "State Key High-tech Enterprise". Covering an area of 7 hectares and a total floor space of 28,000 sq.m, the LVP production line and auxiliary equipment were introduced from Europe and USA. International GMP standard is strictly followed in production. We have 32 sales regional offices in China and 2 subsidiaries in Russia and USA.
As "State Basic Drug" and "State Medical Insurance Drug", the company mainly produces botanical anticancer drug Kanglaite Injection (KLT) which is a novel dual-function and molecular targeted emulsion with active substance extracted from a TCM herb "semen coicis". KLT has remarkable function in inhibiting and killing cancer cells while strengthening immune function. It has significant effectiveness in controlling cancerous pain, resisting cachexia, preventing cancer metastasis and recurrence, improving KPS, QOL and MST and effectively prolonging patient survival.
KLT has full intellectual property. Its chemical component, process technology and application have obtained patent certificates from over 10 countries in the world. In 2001 FDA approved KLT to start clinical study in USA and the Russian Ministry of Health issued KLT registration certificate in December 2003 and launched in July 2004 in Russia with great success. And registration in Saudi Arabia, Yemen, Vietnam, Peru, Pakistan and Thailand, etc. have also been conducted from 2007.
We are seeking overseas agent to register, import and distribute KLT with preferential policy. Contact us NOW.
Products more
Selling Leads more
-
Company Profile Company Name: Zhejiang Kanglaite Pharmaceutical Co., Ltd. Business Type: Product/Service: Anticancer botanical medicine for infusion: Kanglaite Injection Number of Employees:
- Related Factory Company Importers
- anticancer cancer therapy agent infusion medicine anticancer botanical medicine for infusion: kanglaite injection